Sheldon H, Duncan N, Singh A, Endrizzi S, Conrardy R, Brazauskas R, Peppard W. Naloxone coprescribing best practice advisory for patients at high risk for opioid-related adverse events. J of Opioid Management [Internet]. 2024 Dec. 1 [cited 2024 Dec. 22];20(6):471-86. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/3744